Novovax’s COVID vaccine gets emergency use nod for adolescents aged 12-18 yrs in India
The statement further said that Covovax is the fourth vaccine to receive EUA from the DCGI for use among adolescents 12 and older.
The statement further said that Covovax is the fourth vaccine to receive EUA from the DCGI for use among adolescents 12 and older.
"This is yet another milestone in our fight against Covid-19. Covovax is now WHO approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration," Serum Institute of India CEO Adar Poonawala said.
Covovax is the Indian version of the Novovax vaccine brought in India by the Serum Institute of India for children.
